A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

NCT07088926 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

435

Enrollment

INDUSTRY

Sponsor class

Conditions

Bronchiectasis With Pseudomonas Aeruginosa Colonization

Interventions

BIOLOGICAL: AZD0292
OTHER: Placebo

Sponsor

AstraZeneca